Re: “Sex and Gender-Related Differences in COVID-19 Diagnoses and SARS-CoV-2 Testing Practices During the First Wave of the Pandemic: The Dutch Lifelines COVID-19 Cohort Study” by Ballering et al.
Restricted accessLetterFirst published online June, 2022
Re: “Sex and Gender-Related Differences in COVID-19 Diagnoses and SARS-CoV-2 Testing Practices During the First Wave of the Pandemic: The Dutch Lifelines COVID-19 Cohort Study” by Ballering et al.
BalleringAV, Oertelt-PrigioneS, Olde HartmanTC, et al.Sex and gender-related differences in COVID-19 diagnoses and SARS-CoV-2 testing practices during the first wave of the pandemic: The dutch lifelines COVID-19 cohort study. J Women's Health (Larchmt), 2021; 30:1686–1692.
2.
PijlsBG, JolaniS, AtherleyA, et al.Demographic risk factors for COVID-19 infection, severity, ICU admission and death: A meta-analysis of 59 studies. BMJ Open, 2021; 11:e044640.
3.
Italian Institute of Health. Available at: https://www.epicentro.iss.it/coronavirus/sars-cov-2-sorveglianza-dati Accessed January30, 2021.
4.
HoffmannM, Kleine-WeberH, SchroederS, et al.SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 2020; 181:271–280.e8.
5.
KleinSL, FlanaganKL. Sex differences in immune responses. Nat Rev Immunol, 2016; 16:626–638.
6.
SeelandU, ColuzziF, SimmacoM, et al.Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med, 2020; 18:369.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
